Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers

BACKGROUND: Multidrug resistance (MDR) is one of the major obstacles to successful cancer chemotherapy. Developing efficient strategies to reverse MDR remains a major challenge. Surfactin (SUR), a cyclic lipopeptide biosurfactant, has been found to display anticancer activity. METHODS: In this paper...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wenjing, Lang, Yan, Hakeem, Abdul, Lei, Yan, Gan, Lu, Yang, Xiangliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868599/
https://www.ncbi.nlm.nih.gov/pubmed/29606866
http://dx.doi.org/10.2147/IJN.S157368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868599/
https://www.ncbi.nlm.nih.gov/pubmed/29606866
http://dx.doi.org/10.2147/IJN.S157368

Ejemplares similares